Completed PHASE2 INTERVENTIONAL NCT00209534

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

A Phase 2, Two Part Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

Sponsor: Bio Analytical Research Corporation

Conditions Colon Polyps Colonoscopy

Interventions fospropofol disodium

Updated 6 times since 2017 Last updated: Dec 3, 2009 Started: Jan 31, 2003 Completion: Feb 29, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00209534, this PHASE2 trial focuses on Colon Polyps and Colonoscopy and remains completed. Sponsored by Bio Analytical Research Corporation, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bio Analytical Research Corporation
Eisai Inc.
HHI Clinical Research (Biostatistics)
MDS Pharma Services
Omnicare Clinical Research
The Coghlan Group (Plasma Sample Supplies)

Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.